Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of anti-fgl1 antibody and use thereof

An antibody and antigen technology, applied in the direction of antibodies, applications, anti-tumor drugs, etc., can solve the problem of low anti-FGL1 antibodies, achieve high binding activity, good stability, and enhance the effect of anti-tumor effects

Active Publication Date: 2022-07-05
SHANDONG BIOANTY BIOLOGICAL TECH CO LTD
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in the prior art, there are few reports about anti-FGL1 antibodies

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of anti-fgl1 antibody and use thereof
  • A kind of anti-fgl1 antibody and use thereof
  • A kind of anti-fgl1 antibody and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Example 1. Generation of anti-FGL1 monoclonal antibodies

[0042] 1.1 Immunization

[0043] The fully human antibody transgenic mice BoAn-hMab (Shandong Boan Biotechnology Co., Ltd.) were immunized with FGL1 (Bepsis, FG1-H52Hy) and mGM-CSF (Yiqiao Shenzhou, 51048-M07H) and Freund's adjuvant after emulsification. ). A total of 11 mice were immunized with Freund's complete adjuvant for the first immunization, and Freund's incomplete adjuvant for the second to fifth immunization, all of which were injected subcutaneously. 11 mice were boosted by intraperitoneal injection of the same dose of antigen and adjuvant with the second to fifth immunization, and sacrificed 3 days later, and the spleen was taken out for phage library establishment.

[0044] 1.2 Establishment of phage library

[0045] Take the spleen cells of the immunized mice, extract RNA, and then reverse-transcribe to obtain cDNA. The establishment of phage library is carried out according to the method descri...

Embodiment 2

[0073]Example 2. PK activity of CA352 antibody in mice

[0074] Take 3 BALB / c mice, after intravenous injection of 5mg / kg CA352 antibody, before administration (0 h) and 5min, 30min, 1h, 3h, 6h, 24h, 48h, 96h, 168h, 240h after administration , 336h, 384h, and 432h, the blood was collected from the mouse orbit, the blood sample was placed in a collection tube, and allowed to coagulate naturally in an ice box. After the blood sample was taken out, 8h was built in a centrifuge, and centrifuged at 1000-3000 g for 10min to separate the serum. In the sample storage tube, Elisa was used to detect the metabolism of CA352 antibody in BALB / c mice. The results are shown in image 3 and Table 7. from image 3 It can be seen from the PK data of CA352 in BALB / c mice in Table 7 that the half-life of CA352 in vivo is 118 hours, which is relatively stable.

[0075] Table 7

[0076]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a FGL1 antibody or an antigen-binding fragment thereof. The FGL1 antibody or its antigen-binding fragment has high binding activity to FGL1 protein, and can realize the blocking of the binding of FGL1 protein and LAG3 protein, and the combination of FGL1 protein and expression. Blockade of cellular binding of LAG3 protein. The present invention also relates to a nucleic acid encoding the FGL1 antibody or an antigen-binding fragment thereof; a cell containing the nucleic acid; a composition containing the FGL1 antibody or an antigen-binding fragment thereof, the nucleic acid, the cell; containing the FGL1 Kits for antibodies or antigen-binding fragments thereof, nucleic acids, and compositions; and the FGL1 antibody or antigen-binding fragments thereof, nucleic acids, and compositions in the preparation of reagents for detecting, diagnosing tumors, or treating tumors. application in medicine.

Description

technical field [0001] The present invention relates to the field of biotechnology, in particular to an anti-FGL1 antibody and use thereof. Background technique [0002] LAG-3, lymphocyte activation gene-3 (Lymphocyte activation gene-3) belongs to the immunoglobulin superfamily and is a type I transmembrane protein composed of 498 amino acids, which can be selectively expressed in activated T lymphocytes , NK cells and dendritic cells. The regulatory function of LAG-3 protein on T cells is similar to that of PD-1, mainly acting as a receptor for delivering inhibitory signals. [0003] At present, most scientists believe that MHC-II is the main ligand used by cancer cells to bind LAG-3 molecules and thereby reduce the activity of T cells. Therefore, blocking the binding of LAG3 to MHC-II will help activate the anti-cancer ability of T cells. However, , several monoclonal antibodies that do not block the binding of LAG-3 to MHC-II have shown the ability to activate T cells, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/18C12N15/13C12P21/02A61K39/395A61P35/00A61P35/02G01N33/577G01N33/574
CPCC07K16/18C07K16/005A61P35/00A61P35/02G01N33/577G01N33/57484C07K2317/56C07K2317/565C07K2317/52C07K2317/73C07K2317/92A61K2039/505G01N2333/47
Inventor 徐洪光宋德勇仉慧敏刘红窦昌林
Owner SHANDONG BIOANTY BIOLOGICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com